UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005739 |
|---|---|
| Receipt number | R000006758 |
| Scientific Title | Phase ll trial of TS-1 + CDDP + Trastuzumab(SPT)-3 weekly schedule in HER2-positive advanced gastric cancer(HERBIS-1) (OGSG 1101) |
| Date of disclosure of the study information | 2011/06/10 |
| Last modified on | 2022/11/06 12:47:08 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/06/07 23:30:24 | ||
| 2 | Update | 2011/08/10 18:49:12 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2011/08/10 18:50:33 | Recruitment status |
|
| 4 | Update | 2011/08/10 18:51:48 | Public title |
|
| 5 | Update | 2011/08/11 17:35:08 | Public title |
|
| 6 | Update | 2011/11/11 18:33:09 | Acronym |
|
| 7 | Update | 2011/11/22 19:16:18 | Anticipated trial start date Last follow-up date |
|
| 8 | Update | 2012/06/24 22:45:29 | Public title Public title Acronym Acronym |
|
| 9 | Update | 2012/06/24 22:46:04 | Recruitment status |
|
| 10 | Update | 2012/06/24 22:49:10 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL |
|
| 11 | Update | 2012/07/09 23:12:25 | Public title Public title Acronym Acronym |
|
| 12 | Update | 2012/12/07 21:28:03 | Last follow-up date |
|
| 13 | Update | 2013/06/09 21:53:04 | Anticipated trial start date Last follow-up date |
|
| 14 | Update | 2013/06/09 21:58:18 | Anticipated trial start date Last follow-up date |
|
| 15 | Update | 2014/12/16 21:43:35 | Recruitment status |
|
| 16 | Update | 2015/06/11 23:37:54 | TEL TEL |
|
| 17 | Update | 2016/10/19 22:48:06 | Email Name of primary person or sponsor Organization |
|
| 18 | Update | 2017/02/12 23:56:39 | URL releasing protocol Publication of results |
|
| 19 | Update | 2018/04/30 23:26:12 | Email |
|
| 20 | Update | 2018/04/30 23:33:44 | Results Results |
|
| 21 | Update | 2018/05/10 20:27:17 | Email |
|
| 22 | Update | 2020/01/05 14:33:53 | Date of IRB |
|
| 23 | Update | 2020/01/05 14:48:38 | URL related to results and publications Number of participants that the trial has enrolled Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 24 | Update | 2020/01/05 18:10:48 | URL releasing protocol Results Results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 25 | Update | 2020/01/22 21:34:52 | Date of IRB |
|
| 26 | Update | 2022/11/06 12:47:08 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
